Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 06 Jul 2026 for Vertex Pharmaceuticals INC / MA, €366k. Read the official filing
Filing timeline
BuySaleJoy Liu
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joy Liu: trading record in brief
Joy Liu (senior executive) discloses dealings in Vertex Pharmaceuticals INC / MA to SEC (Form 4). Between 17 May 2021 and 1 July 2026, the trades on record add up to 13 filings.
No open-market purchase appears, only 9 sales worth €1.5M. Outside the open market, there are 4 share grants. 2026 to date brings no purchases and 3 sales.
The latest filing, published on 6 July 2026, reports an open-market sale of €366k in Vertex Pharmaceuticals INC / MA. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joy Liu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
13 of 13 declarations
